Researchers have unveiled a way to flip genes back on without slicing into the genome, a shift that could make CRISPR far ...

A brand-new paper has just been published that claims to challenge the century-old dogma that Alzheimer’s disease is ...

A deep dive into the Fc–FcR axis as a therapeutic anchor in autoimmune disease, examining immune signaling and drug ...

Researchers at the German Cancer Research Center and Heidelberg University showed that cells regulated inflammation through ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle ...

Cancer evolves through layers of change: mutations in DNA, shifts in gene regulation, altered cell behaviour, and dynamic ...

As the biopharma industry heads into 2026, insights gained over the past year are set to be applied and scaled, especially in ...

A new drug candidate shows promise by reversing cognitive decline in advanced Alzheimer's disease by restoring brain balance ...

A massive global genetics study is reshaping how we understand mental illness—and why diagnoses so often pile up. By analyzing genetic data from more than six million people, researchers uncovered ...

In July 1930, Rabindranath Tagore visited Albert Einstein in Caputh, near Berlin, at his summerhouse. The meeting of the two ...

Scurfy” mice, DNA sequencing and a Seattle biotechnology company were integral to the research that Mary E. Brunkow conducted ...

January 2026 Consumer Search Analysis Examines How Shoppers Evaluate Single-Ingredient vs Multi-Ingredient Berberine ...